Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: GlaxoSmithKline plc

Market Cap 78.74B 105B 90.99B 83.66B 148B 9,954B 149B 991B 386B 4,885B 396B 387B 16,900B P/E 2026 *
12.7x
P/E 2027 * 11.7x
Enterprise Value 92.99B 125B 107B 98.8B 175B 11,756B 176B 1,171B 456B 5,770B 468B 458B 19,959B EV / Sales 2026 *
2.75x
EV / Sales 2027 * 2.53x
Free-Float
92.29%
Yield 2026 *
3.55%
Yield 2027 * 3.72%
Manager TitleAgeSince
Chief Executive Officer - 31/12/2025
Director of Finance/CFO 64 30/04/2023
Chief Tech/Sci/R&D Officer - 30/11/2021
Director TitleAgeSince
Director/Board Member - 05/05/2026
Director/Board Member 64 31/12/2017
Chairman 68 31/08/2019
Change 5-day change 1-year change 3-year change Capi.($)
-0.94%-2.14%+40.54%+148.38% 992B
-0.42%-1.80%+53.69%+42.60% 564B
-0.56%-1.65%+19.27%+59.57% 391B
0.00%+0.68%+24.66%+16.53% 330B
-0.04%-0.77%+27.74%+15.70% 280B
+0.01%-0.23%+27.68%+33.47% 279B
-0.19%+1.03%-40.84%-47.28% 196B
-1.78%+1.16%+17.79%+48.77% 184B
-1.40%+3.27%+16.16%+59.08% 156B
Average -0.60%+0.41%+20.74%+41.87% 374.58B
Weighted average by Cap. -0.59%-0.49%+29.49%+66.01%

Financials

2026 *2027 *
Net sales 33.78B 45.25B 39.04B 35.89B 63.48B 4,271B 64.02B 425B 166B 2,096B 170B 166B 7,251B 35.48B 47.52B 41B 37.69B 66.66B 4,485B 67.22B 447B 174B 2,201B 178B 175B 7,614B
Net income 6.27B 8.39B 7.24B 6.66B 11.77B 792B 11.87B 78.9B 30.72B 389B 31.5B 30.83B 1,345B 6.67B 8.93B 7.71B 7.09B 12.53B 843B 12.64B 83.97B 32.69B 414B 33.53B 32.81B 1,431B
Net Debt 14.25B 19.09B 16.47B 15.14B 26.78B 1,802B 27.01B 179B 69.86B 884B 71.65B 70.12B 3,059B 11.19B 14.99B 12.93B 11.89B 21.03B 1,414B 21.2B 141B 54.85B 694B 56.25B 55.05B 2,402B
Logo GlaxoSmithKline plc
GSK plc is the world's No. 2 pharmaceutical group. Net sales break down by family of products as follows: - pharmaceutical products (41.3%): intended mainly for HIV infection (57% of net sales), immune system disorders and respiratory diseases (28.3%), and cancer (14.7%); - OTC and parapharmaceutical medicine (30.7%); - vaccines (28%). Net sales are distributed geographically as follows: the United Kingdom (2.1%), Europe (21%), the United States (51.6%), and other (25.3%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!